NYMC Faculty Publications
Clinicopathologic Consequences Following Discontinuation of Rifaximin in Patients with Sickle Cell Disease
Journal Title
American Journal of Hematology
First Page
151
Last Page
153
Document Type
Article
Publication Date
6-2020
Department
Medicine
Recommended Citation
Lim, S. H., & Dutta, D. (2020). Clinicopathologic Consequences Following Discontinuation of Rifaximin in Patients with Sickle Cell Disease. American Journal of Hematology, 95 (6), 151-153. https://doi.org/10.1002/ajh.25798
COinS